GLOBAL BIOSURGERY MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

GLOBAL BIOSURGERY MARKET 2021-2028

Market by Product, Application, Source Type, and Geography | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research’s report on the global biosurgery market denotes that based on value, the market is anticipated to surge at a CAGR of 6.21% during the forecasting years 2021-2028. In 2020, the market acquired revenue worth $8516.6 million, and is predicted to reap $15390.1 million by 2028.


Report scope can be customized per your requirements. Request For Customization

Biosurgical products are innovative solutions that treat complex surgical conditions, prevent excessive blood loss, and offer wound sealing. These factors have increased the demand for biological products for application in critical and expensive surgeries.

Factors such as the rising number of surgical procedures and technological advancements are driving the growth of the studied market. Besides, the increasing geriatric population is likely to boost the development of the biosurgery market. For instance, more than 80% of fractures in people above 50 years are caused by osteoporosis. Here, the bone density diminishes after 30 years, thereby resulting in bones breaking easily.

Triton’s report aims to get an overview of the biosurgery market in terms of various factors. Within this report, the key insight and the market summary regarding the biosurgery market have been discussed. Also, the Impact of COVID-19 on the global market, Porter’s five forces model, trends in biosurgery technology, market attractiveness matrix, vendor scorecard, and key insights have been studied in detail.

Furthermore, the innovations in healthcare facilities, the surge in surgical treatments for musculoskeletal disorders, the prevalence of spinal fusion and joint reconstruction, and the strong focus on R&D are other key factors supplementing the studied market’s progress. Additionally, the development of policies for reimbursement and compensation is generating new opportunities for the market to leverage to reach its expected growth.

However, several restraints, such as the high cost of surgeries, complications related to immune response, and the use of minimally invasive surgeries, obstruct the global market’s growth.



Major geographies covered in the biosurgery market are:

•           North America: Canada and United States

•           Asia-Pacific: Australia & New Zealand, Japan, India, ASEAN countries, South Korea, China, and Rest of Asia-Pacific

•           Europe: Russia, Spain, United Kingdom, Germany, France, Italy, and Rest of Europe

•           Latin America: Mexico, Brazil, and Rest of Latin America

•           Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa

The segmentation analysis of the biosurgery market includes:

•           Market by Product:

           o          Hemostatic Agents

           o          Bone-Graft Substitutes

                      •          Synthetic Graft Extenders

                      •          Demineralized Bone Matrix

                      •          Bone Morphogenetic Proteins

                      •          Cell-Based Matrices

           o          Surgical Sealing Agents

                      •          Natural

                      •          Synthetic

           o          Soft-Tissue Management

                      •          Natural Mesh/Patch

                      •          Synthetic Mesh/Patch

           o          Anti-Adhesive Agents

           o          Staple Line Reinforcement

•           Market by Application:

           o          Orthopedic Surgery

           o          Cardio and Thoracic Surgery

           o          Neuro and Spine Surgery

           o          General Surgery

           o          Other Applications

•           Market by Source Type:

           o          Natural

           o          Synthetic

The renowned companies thriving in the biosurgery market include Medtronic Plc, Zimmer Biomet Holdings Inc, Baxter International Inc, Ethicon Inc (Johnson & Johnson), Stryker Corporation, Becton, Dickinson and Company, RTI Surgical, B Braun Melsungen AG, Integra Lifesciences Holdings Corporation, Sanofi, Wright Medical Group NV, CSL Limited, and Smith & Nephew Plc.  

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL BIOSURGERY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON BIOSURGERY MARKET

2.2. TRENDS IN BIOSURGERY TECHNOLOGY

2.3. KEY INSIGHTS

2.4. PORTER’S FIVE FORCES MODEL

2.4.1. THREAT OF NEW ENTRANTS

2.4.2. THREAT OF SUBSTITUTE PRODUCTS

2.4.3. BARGAINING POWER OF BUYERS

2.4.4. BARGAINING POWER OF SUPPLIERS

2.4.5. COMPETITIVE RIVALRY

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. KEY BUYING OUTLOOK

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS AND PARTNERSHIPS

2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.8.3. ACQUISITIONS & MERGERS

2.8.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS

2.9. MARKET DRIVERS

2.9.1. GROWING AGING POPULATION

2.9.2. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN HEALTHCARE FACILITIES

2.9.3. SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS

2.9.4. PREVALENCE OF SPINAL FUSION AND JOINT RECONSTRUCTION

2.9.5. STRONG FOCUS ON RESEARCH AND DEVELOPMENT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST OF SURGERIES

2.10.2. COMPLICATIONS RELATED TO IMMUNE RESPONSE

2.10.3. USAGE OF MINIMALLY INVASIVE SURGERIES

2.11. MARKET OPPORTUNITIES

2.11.1. RESEARCH AND INVESTMENTS IN BIOENGINEERING

2.11.2. DEVELOPMENT OF POLICIES FOR REIMBURSEMENT AND COMPENSATION

3. GLOBAL BIOSURGERY MARKET - BY PRODUCT

3.1. HEMOSTATIC AGENTS

3.2. BONE-GRAFT SUBSTITUTES

3.2.1. SYNTHETIC GRAFT EXTENDERS

3.2.2. DEMINERALIZED BONE MATRIX

3.2.3. BONE MORPHOGENETIC PROTEINS

3.2.4. CELL-BASED MATRICES

3.3. SURGICAL SEALING AGENTS

3.3.1. NATURAL

3.3.2. SYNTHETIC

3.4. SOFT-TISSUE MANAGEMENT

3.4.1. SYNTHETIC MESH/PATCH

3.4.2. NATURAL MESH/PATCH

3.5. ANTI-ADHESIVE AGENTS

3.6. STAPLE LINE REINFORCEMENT

4. GLOBAL BIOSURGERY MARKET - BY APPLICATION

4.1. ORTHOPEDIC SURGERY

4.2. CARDIO AND THORACIC SURGERY

4.3. NEURO AND SPINE SURGERY

4.4. GENERAL SURGERY

4.5. OTHER APPLICATIONS

5. GLOBAL BIOSURGERY MARKET - BY SOURCE TYPE

5.1. NATURAL

5.2. SYNTHETIC

6. GLOBAL BIOSURGERY MARKET - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1. MARKET BY PRODUCT

6.1.1.1. BONE-GRAFT SUBSTITUTES MARKET BY TYPE

6.1.1.2. SURGICAL SEALING AGENTS MARKET BY TYPE

6.1.1.3. SOFT-TISSUE MANAGEMENT MARKET BY TYPE

6.1.2. MARKET BY APPLICATION

6.1.3. MARKET BY SOURCE TYPE

6.1.4. COUNTRY ANALYSIS

6.1.4.1. UNITED STATES

6.1.4.2. CANADA

6.2. EUROPE

6.2.1.   MARKET BY PRODUCT

6.2.1.1. BONE-GRAFT SUBSTITUTES MARKET BY TYPE

6.2.1.2. SURGICAL SEALING AGENTS MARKET BY TYPE

6.2.1.3. SOFT-TISSUE MANAGEMENT MARKET BY TYPE

6.2.2. MARKET BY APPLICATION

6.2.3. MARKET BY SOURCE TYPE

6.2.4. COUNTRY ANALYSIS

6.2.4.1. GERMANY

6.2.4.2. UNITED KINGDOM

6.2.4.3. FRANCE

6.2.4.4. ITALY

6.2.4.5. SPAIN

6.2.4.6. RUSSIA

6.2.4.7. REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1. MARKET BY PRODUCT

6.3.1.1. BONE-GRAFT SUBSTITUTES MARKET BY TYPE

6.3.1.2. SURGICAL SEALING AGENTS MARKET BY TYPE

6.3.1.3. SOFT-TISSUE MANAGEMENT MARKET BY TYPE

6.3.2. MARKET BY APPLICATION

6.3.3. MARKET BY SOURCE TYPE

6.3.4. COUNTRY ANALYSIS

6.3.4.1. CHINA

6.3.4.2. JAPAN

6.3.4.3. INDIA

6.3.4.4. AUSTRALIA & NEW ZEALAND

6.3.4.5. SOUTH KOREA

6.3.4.6. ASEAN COUNTRIES

6.3.4.7. REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1. MARKET BY PRODUCT

6.4.1.1. BONE-GRAFT SUBSTITUTES MARKET BY TYPE

6.4.1.2. SURGICAL SEALING AGENTS MARKET BY TYPE

6.4.1.3. SOFT-TISSUE MANAGEMENT MARKET BY TYPE

6.4.2. MARKET BY APPLICATION

6.4.3. MARKET BY SOURCE TYPE

6.4.4. COUNTRY ANALYSIS

6.4.4.1. BRAZIL

6.4.4.2. MEXICO

6.4.4.3. REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY PRODUCT

6.5.1.1. BONE-GRAFT SUBSTITUTES MARKET BY TYPE

6.5.1.2. SURGICAL SEALING AGENTS MARKET BY TYPE

6.5.1.3. SOFT-TISSUE MANAGEMENT MARKET BY TYPE

6.5.2. MARKET BY APPLICATION

6.5.3. MARKET BY SOURCE TYPE

6.5.4. COUNTRY ANALYSIS

6.5.4.1. SAUDI ARABIA

6.5.4.2. UNITED ARAB EMIRATES

6.5.4.3. TURKEY

6.5.4.4. SOUTH AFRICA

6.5.4.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. BAXTER INTERNATIONAL INC

7.2. BECTON, DICKINSON AND COMPANY

7.3. B BRAUN MELSUNGEN AG

7.4. CSL LIMITED

7.5. ETHICON INC (JOHNSON & JOHNSON)

7.6. INTEGRA LIFESCIENCES HOLDINGS CORPORATION

7.7. MEDTRONIC PLC

7.8. RTI SURGICAL

7.9. SANOFI

7.10. SMITH & NEPHEW PLC

7.11. STRYKER CORPORATION

7.12. WRIGHT MEDICAL GROUP NV

7.13. ZIMMER BIOMET HOLDINGS INC

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       GLOBAL BIOSURGERY MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       CONTRACTS AND PARTNERSHIPS

TABLE 4:       BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

TABLE 5:       ACQUISITIONS & MERGERS

TABLE 6:       NEW PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7:       AGING POPULATION AROUND THE WORLD 2019 & 2050

TABLE 8:       GLOBAL BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 9:       GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10:     GLOBAL SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 11:     GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 12:     GLOBAL BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 13:     GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

TABLE 14:     GLOBAL BIOSURGERY MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 15:     NORTH AMERICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 16:     NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 17:     NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 18:     NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 19:     NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 20:     NORTH AMERICA BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 21:     NORTH AMERICA BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

TABLE 22:     EUROPE BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 23:     EUROPE BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 24:     EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 25:     EUROPE SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 26:     EUROPE SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 27:     EUROPE BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 28:     EUROPE BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

TABLE 29:     ASIA-PACIFIC BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 30:     ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 31:     ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 32:     ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 33:     ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 34:     ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 35:     ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

TABLE 36:     LATIN AMERICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 37:     LATIN AMERICA BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 38:     LATIN AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 39:     LATIN AMERICA SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 40:     LATIN AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 41:     LATIN AMERICA BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 42:     LATIN AMERICA BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

TABLE 43:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 44:     MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 45:     MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 46:     MIDDLE EAST AND AFRICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 47:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 48:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     GLOBAL BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     GLOBAL BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN%)

FIGURE 3:     GLOBAL BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 4:     GLOBAL BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 5:     GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)

FIGURE 6:     GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)

FIGURE 7:     GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)

FIGURE 8:     GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)

FIGURE 9:     GLOBAL BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 10:  GLOBAL SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 11:  GLOBAL SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 12:  GLOBAL BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)

FIGURE 13:  GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 14:  GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 15:  GLOBAL BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 16:  GLOBAL BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)

FIGURE 17:  GLOBAL BIOSURGERY MARKET, BY APPLICATION, 2020 & 2028 (IN%)

FIGURE 18:  GLOBAL BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 19:  GLOBAL BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 20:  GLOBAL BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21:  GLOBAL BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 22:  GLOBAL BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 23:  GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, 2020 & 2028 (IN%)

FIGURE 24:  GLOBAL BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 25:  GLOBAL BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 26:  UNITED STATES BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  CANADA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  GERMANY BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29:  UNITED KINGDOM BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30:  FRANCE BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31:  ITALY BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 32:  SPAIN BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 33:  RUSSIA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 34:  REST OF EUROPE BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 35:  CHINA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 36:  JAPAN BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 37:  INDIA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 38:  AUSTRALIA & NEW ZEALAND BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 39:  SOUTH KOREA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 40:  ASEAN COUNTRIES BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 41:  REST OF ASIA-PACIFIC BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 42:  BRAZIL BIOSURGERY MARKET 2021-2028 ($ MILLION)

FIGURE 43:  MEXICO BIOSURGERY MARKET 2021-2028 ($ MILLION)

FIGURE 44:  REST OF LATIN AMERICA BIOSURGERY MARKET 2021-2028 ($ MILLION)

FIGURE 45:  SAUDI ARABIA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 46:  UNITED ARAB EMIRATES BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 47:  TURKEY BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 48:  SOUTH AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 49:  REST OF MIDDLE EAST & AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;